Report Categories
View AllRecent Articles
View All
BLW Blackrock investors seek clarity on fixed income portfolio returns following its latest quarterly earnings release
Is Athene ATHS stock underperforming
Moderna Inc MRNA LNP Patent Resolution With Arbutus Biopharma Clears LongTerm Operational Overhang
ANRO Alto Neuro Q4 2025 EPS trails estimates by 71 percent sending shares down 069 percent today
RNP Cohen and management highlights stable portfolio performance in latest quarterly earnings update
ConocoPhillips COP Undervaluation and Q1 Earnings Beat Potential Signal Compelling Buying Opportunity
IBRX ImmunityBio reports narrower than projected Q4 2025 per share loss while its stock holds steady for the trading session